Results 1 to 10 of about 253 (70)

Ileo-perineal fistula: Rare late complication after rectal amputation – clinical case [PDF]

Romanian Medical Journal, 2021
Abdominal-perineal rectal amputation retains a well-defined place in the surgical treatment of rectal cancer, despite technical advances. The authors present the case of a 67-year-old patient who developed an entero-perineal fistula involving the last ...
Andrei Iulian Toader, Călin Pavel Cobelschi, Aurel Mironescu, Alfred Redalf Alain Gheorghiu, Adrian Maier, Andreea Mădălina Toader   +5 more
doaj   +1 more source

Liver metastasis from rectal neuroendocrine neoplasm detected 15 years after primary resection

Surgical Case Reports, 2022
Background Rectal neuroendocrine neoplasms can induce liver metastasis. However, few reports exist on the associated long-term recurrence rates. We report a case of liver metastasis identified 15 years after rectal neuroendocrine neoplasm resection. Case
Miho Akabane, Satoshi Okubo, Keiichi Kinowaki, Masaru Matsumura, Junichi Shindoh, Masaji Hashimoto   +5 more
doaj   +1 more source

Tumour-to-tumour metastasis: Rectal adenocarcinoma metastasis to medullary carcinoma of thyroid—Case report and review of the literature

Human Pathology Reports, 2022
Tumour-to-tumour metastasis is a rare incidence. Metastasis from colorectal cancer to primary thyroid neoplasm is extremely rare. We report a case of metastatic rectal adenocarcinoma to a medullary thyroid carcinoma.
Mahmoud Elsayed, Andrew McCarthy, Marium Khan   +2 more
doaj   +1 more source

Metastatic rectal cancer to papillary thyroid carcinoma: a case report and review of literature

BMC Gastroenterology, 2020
Background Tumor-to-tumor metastasis is a rare event. Rectal cancer to primary thyroid neoplasm metastasis is extremely rare. Herein, we reported a case of metastatic rectal adenocarcinoma to a papillary thyroid carcinoma.
Min Luo, Yu Huang, Yongqiang Li, Yumei Zhang   +3 more
doaj   +1 more source

Surgical outcomes of robotic transanal minimally invasive surgery for selected rectal neoplasms: A single-hospital experience

Asian Journal of Surgery, 2020
Summary: Background: Rectal neoplasm is one of the most common malignancies worldwide. Screening programs for rectal neoplasm result in early diagnosis and a decrease in disease-related mortality and morbidity.
Yan-Jiun Huang, Yu-Min Huang, Wei-Lin Wang, Yiu-Shun Tong, Wayne Hsu, Po-Li Wei   +5 more
doaj   +1 more source

Pattern of Rectal Cancer Recurrence Following Potentially Curative Surgical Treatment

Journal of Coloproctology, 2022
Survival in rectal cancer has been related mainly to clinical and pathological staging. Recurrence is the most challenging issue when surgical treatment of rectal cancer is concerned.
Gustavo Sevá-Pereira, Vitória de Souza Oliveira, Gabriela Domingues Andrade Ribeiro, Paula Buozzi Tarabay, Marcello Imbrizzi Rabello, Joaquim José de Oliveira-Filho   +5 more
doaj   +1 more source

Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients [PDF]

Annals of Coloproctology, 2019
Purpose Adjuvant chemotherapy (aCT) in rectal cancer patients who have undergone curative resection after neoadjuvant chemoradiation (nCRT) is controversial.
Youn Young Park, Kang Young Lee, Nam Kyu Kim, Sat Byol Lee, Ga Ram Kim, Byung Soh Min, Seong-Taek Oh   +6 more
doaj   +1 more source

Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review

BMC Surgery, 2019
Background Pseudomyxoma peritonei (PMP) is a disease involving the peritoneum characterized by the production of large quantities of mucinous ascites. PMP has a low incidence, is difficult to diagnose, and has a guarded prognosis.
Shili Ning, Yanliang Yang, Chen Wang, Fuwen Luo   +3 more
doaj   +1 more source

Is preoperative chemoradiotherapy warranted in magnetic resonance imaging-based clinically T3N0 rectal cancer? [PDF]

Korean Journal of Clinical Oncology, 2014
Purpose: Preoperative chemoradiotherapy (PCRT) has been widely adopted. However, benefit of PCRT for patients with clinically T3N0 (cT3N0) rectal cancer is doubtful.
Jee Yeon Kim, In Ja Park, Chang Sik Yu, Seok-Byung Lim, Jong Lyul Lee, Yong Sik Yoon, Chan Wook Kim, Jin Cheon Kim   +7 more
doaj   +1 more source

Metabolic dysfunction and early‐onset colorectal cancer – how macrophages build the bridge

Cancer Medicine, 2020
Background The incidence of colorectal cancer (CRC) among patients
Katharina M. Scheurlen, Adrian T. Billeter, Stephen J. O'Brien, Susan Galandiuk   +3 more
doaj   +1 more source